SCHEMBL3368868

SCHEMBL3368868

Cc1ccc2c(c1)C(C)(C)CC2=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 5/20 0.69
KDM4E B2RXH2 5/20 0.41
ATM Q13315 2/20 0.41
HTT P42858 2/20 0.41
METAP1 P53582 2/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
MAOB P27338 2/20 0.39
MAOA P21397 1/20 0.39
RAD52 P43351 1/20 0.39
CYP2C19 P33261 1/20 0.39
ELANE P08246 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
HTR2C P28335 1/20 0.38
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4417754 0.87 PGR (0.77) PGRKDM4EATMHTTMAOB
SCHEMBL568994 0.85 PGR (0.55) PGRKDM4EATMHTTMETAP1
SCHEMBL4421269 0.82 PGR (1.00) PGRMAOBALDH1A1
SCHEMBL5648628 0.81 PGR (0.49) PGRKDM4EATMHTTMETAP1
SCHEMBL3361527 0.79 PGR (0.55) PGRKDM4EMETAP1CA1CA2
SCHEMBL13113557 0.79 PGR (0.55) PGRKDM4EHTTCYP2C19ALDH1A1
SCHEMBL388355 0.79 PGR (0.55) PGRKDM4ECA1CA2CA7
SCHEMBL192717 0.79 PGR (0.69) PGRMETAP1MAOBMEN1KMT2A
SCHEMBL20951359 0.79 PGR (0.55) PGRKDM4EHTTCA9MEN1
SCHEMBL388758 0.77 PGR (0.53) PGRKDM4EHTTMETAP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478616-B1 INDANES AND INDANONES AND THEIR USE IN PERFUMERY GIVAUDAN SA (CH) 2010-09-22 EP claimed
US-20050148493-A1 Indanes and indanones and their use in perfumery FLACHSMANN FELIX (CH) 2005-07-07 US claimed
EP-1478616-A1 INDANES AND INDANONES AND THEIR USE IN PERFUMERY Givaudan SA (CH) 2004-11-24 EP claimed
WO-2003072533-A1 INDANES AND INDANONES AND THEIR USE IN PERFUMERY GIVAUDAN SA (CH) 2003-09-04 WO claimed
EP-1340741-A1 Indane derivatives and their use in perfumery Givaudan SA (CH) 2003-09-03 EP claimed
EP-1478616-B1 INDANES AND INDANONES AND THEIR USE IN PERFUMERY GIVAUDAN SA (CH) 2010-09-22 EP disclosed
US-7538243-B2 Indanes and indanones and their use in perfumery GIVAUDAN SA (CH) 2009-05-26 US disclosed
EP-1701934-B1 DISUBSTITUTED CHALCONE OXIMES HAVING RAR(Gamma)-RETINOID RECEPTOR ANTAGONIST ACTIVITY ALLERGAN INC (US) 2009-02-25 EP disclosed
US-20070185057-A1 Novel Indanone Compounds SYMRISE GMBH & CO. KG (DE) 2007-08-09 US disclosed
US-20070185057-A1 Novel Indanone Compounds SYMRISE GMBH & CO. KG (DE) 2007-08-09 US disclosed
US-20070185057-A1 Novel Indanone Compounds SYMRISE GMBH & CO. KG (DE) 2007-08-09 US disclosed
US-7208142-B2 Indanylidene compounds SYMRISE GMBH & CO. KG (DE) 2007-04-24 US disclosed
EP-1341752-B1 NOVEL INDANYLIDENE COMPOUNDS SYMRISE GMBH & CO KG (DE) 2004-08-04 EP disclosed
CN-1473146-A Novel indanylidene compounds ������������� 2004-02-04 CN disclosed
EP-1341752-A1 NOVEL INDANYLIDENE COMPOUNDS HAARMANN & REIMER GMBH (DE) 2003-09-10 EP disclosed
EP-1340741-A1 Indane derivatives and their use in perfumery Givaudan SA (CH) 2003-09-03 EP disclosed
US-20030125584-A1 6-Alkylindan-1-ones as fragrances SYMRISE GMBH & CO. KG (DE) 2003-07-03 US disclosed
EP-1310240-A1 6-Alkylindane-1-ones as perfuming agents HAARMANN & REIMER GMBH (DE) 2003-05-14 EP disclosed
US-20020143203-A1 Novel indanylidene compounds SYMRISE GMBH & CO. KG (DE) 2002-10-03 US disclosed
WO-2002038537-A1 NOVEL INDANYLIDENE COMPOUNDS HAARMANN & REIMER GMBH (DE) 2002-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185057-A1 Novel Indanone Compounds CUTA, NISCH, TYR PGR 3055/4885KDM4E 902/4885ATM 781/4885
US-20030125584-A1 6-Alkylindan-1-ones as fragrances TRPA1, CYP1A1, CYP1B1 PGR 3883/4885KDM4E 2940/4885ATM 2975/4885
US-20020143203-A1 Novel indanylidene compounds CUTA, NISCH, ERCC4 PGR 3741/4885KDM4E 1177/4885ATM 2286/4885
US-20050148493-A1 Indanes and indanones and their use in perfumery NISCH, CYP1B1, CYP2E1 PGR 798/4885KDM4E 2909/4885ATM 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.